ASHRM to Participate in FDA Meeting on Communications About the Safety of Medical Devices
ASHRM President-elect Barbara McCarthy will serve as a panelist during an FDA virtual hearing scheduled for November 17 at Noon CT. The purpose of the meeting is to discuss the development, content and format of the FDA's safety communications about medical devices. The FDA is encouraging ASHRM members to register to attend the meeting or submit a request to speak by November 3